Literature DB >> 25645762

Kidney transplantation with organs from donors after circulatory death type 3: a prospective multicentric Spanish study (GEODAS 3).

J Portolés Pérez1, O Lafuente2, B Sánchez-Sobrino2, M J Pérez Sáez3, A Fernández García4, F Llamas5, P López-Sánchez2, M L Rodriguez-Ferrero6, S Zarraga7, A Ramos8, J Pascual3.   

Abstract

To increase the number of kidney donors, new strategies are needed such as living donor programs, expanded criteria donors, or donors after circulatory death (DCD) kidney transplantation programs. The GEODAS group has started an observational, prospective, multicenter clinical study, collecting data from all DCD type-3 kidney transplantations performed in seven Spanish hospitals from January 2012 to January 2014. The preliminary results have shown a delayed graft function of 40.4% and graft survival of 93.7% with a nadir creatinine of 1.3 mg/dL. From all 33 potential donors included in the study, 32 were effective and 63 kidney grafts were transplanted with a utilization rate of 98.5%. Creatinine evolution (median [range]) was in the first month: 2.1 [0.6-5.6]; third month: 1.6 [0.8, 4.2]; first year: 1.6 [0.9-2.2]. These results are similar to kidney transplantation from donors after brain death as shown in the literature, especially in the graft and recipient survival rates. In addition, the controlled programs are easier and less expensive than uncontrolled DCD programs with a higher rate of graft use.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25645762     DOI: 10.1016/j.transproceed.2014.12.008

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  1 in total

1.  Early outcomes of kidney transplantation from elderly donors after circulatory death (GEODAS study).

Authors:  María José Pérez-Sáez; Omar Lafuente Covarrubias; Domingo Hernández; Francesc Moreso; Edoardo Melilli; Javier Juega; Erika de Sousa; Paula López-Sánchez; María Luisa Rodríguez-Ferrero; Naroa Maruri-Kareaga; María Dolores Navarro; Rosalía Valero; María Auxiliadora Mazuecos; Francisco Llamas; Paloma Martín-Moreno; Antón Fernández-García; Jordi Espí; Carlos Jiménez; Ana Ramos; Eva Gavela; Julio Pascual; Jose M Portolés
Journal:  BMC Nephrol       Date:  2019-06-26       Impact factor: 2.388

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.